Page 3 - சார்லஸ் நதி ஆய்வகங்கள் சர்வதேச News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Biomarkers Market worth $78 1 billion in 2026 - Exclusive Report by MarketsandMarkets
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Biomarkers Market worth $78 1 billion in 2026 - Exclusive Report by MarketsandMarkets™
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Sterility Testing Market to Reach $620 9 Mn, Globally, by 2027 at 13 5% CAGR
sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.
Viral Clearance Market Growth Forecast at 21.9% CAGR by 2028 Says Reports And Data
iCrowd Newswire
14 Jul 2021, 10:09 GMT+10
Rising demand for biologics, increasing drug approvals and launch of new drugs, and rising prevalence of chronic diseases across the globe are key factors expected to drive market growth
Viral Clearance Market Size – USD 403.5 Million in 2020, Market Growth – at a CAGR of 21.9%, Market Trends – Increasing investment in biopharmaceutical R&D
The global viral clearance market size is expected to reach USD 1,967.68 Million by 2028 at a CAGR of 21.9%, according to the latest report by Reports and Data. Key factors driving market revenue growth include growing global healthcare burden due to increasing prevalence of chronic diseases, increasing private and public funding for biopharmaceutical R&D, rising demand for biologics, and rapid rise in drug discovery and development processes. Technological advancements in nanofiltration and other viral removal m
Clinical Laboratory Tests Market Size 2021 Is Poised To Expand High CAGR By 2028
tusharJuly 10, 2021 Clinical Laboratory Tests Market
The global clinical laboratory tests market is driven by high prevalence of diseases, such as cardiovascular and neurological diseases, rise in geriatric population, development of technologically advanced products, such as biochips and microarrays, and surge in healthcare expenditure. Moreover, preference for preventive medicine, shorter hospital stay, and high demand for integrated analytical systems fuel the market growth. However, control of the FDA over laboratory-based tests delays the launch of new products and lack of skilled professionals in clinics based in emerging economies hamper this growth.